Skip to content

The effect of vitamin D supplementation on reproductive outcomes

A clinical trial to compare the effect of vitamin D supplementation on outcomes of assisted reproduction techniques in infertile women

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015111124999N1
Enrollment
85
Registered
2016-12-30
Start date
2015-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In vitro fertilization. Admission for harvesting or implantation of ova

Interventions

Intervention 1: Intervention group: Gelatin capsule of vitamin D, 50000 units, orally, once a week, for 6 weeks. Intervention 2: Control group: Placebo, Gelatin capsule, orally, once a week, for 6 wee
Treatment - Drugs
Placebo
Intervention group: Gelatin capsule of vitamin D, 50000 units, orally, once a week, for 6 weeks.
Control group: Placebo, Gelatin capsule, orally, once a week, for 6 weeks.

Sponsors

Vice Chancellor for Research of Nursing and Midwifery Faculty, Isfahan University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 38 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Women in the age of 18 to 38 years ; having Primary infertility ; having female infertility approved by gynecologist ; using of long-term down-regulation protocol and then ovulation induction ; not using of vitamin D supplementation before the study ; not having a medical history of systemic disorders such as Cushing's syndrome, hyper or hypothyroidism, hyperprolactimenia ; no liver, kidney and heart diseases ; having BMI Less than or equal to 30 KG/M2 or More than or equal to 18.9 KG/M2 ; not having clinical signs of vitamin D deficiency such as osteomalacia, osteoarthritis, the joint and bone pain and rheumatoid arthritis ; not using of drugs such as Phenytoin, Phenobarbital, Carbamazepine, Isoniazid, Rifampin Theophylline which may affect on vitamin D metabolism ; the absence of congenital or acquired uterine defects ; not having endometriosis. Exclusion criteria: Using surrogate uterine ; using the Oocyte donation ; Unwillingness to continue cooperation ; not having fertile follicle after injection of gonadotropin hormone.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Rate of clinical pregnancy. Timepoint: Four weeks after intervention. Method of measurement: Ultrasound.;Rate Biochemical pregnancy. Timepoint: 7 days after embryo transfer. Method of measurement: Laboratory Kit.;Rate of fertilization. Timepoint: 16 to 18 hours after in vitro fertilization. Method of measurement: Microscope.;Embryo quality. Timepoint: 16 to 18 hours after in vitro fertilization. Method of measurement: Microscope.;Endometrial quality. Timepoint: At the same time oocyte retrieval. Method of measurement: Ultrasound.

Secondary

MeasureTime frame
The number of oocytes. Timepoint: WHEN PICK UP. Method of measurement: Microscope.;Vitamin D serum after intervention. Timepoint: 6 to 8 weeks after intervention. Method of measurement: Laboratory Kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahboubeh Taebi

Nursing and Midwifery faculty of Isfahan

m_taebi@nm.mui.ac.ir+98 31 3776 5064

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 21, 2026